Healthium Medtech to sell UK-based subsidiary Clinisupplies to KKR

Bengaluru: Healthium Medtech announced that it has entered into a definitive agreement to sell its UK-based subsidiary, Clinisupplies to KKR, which is investing through its KKR Health Care Strategic Growth Fund II. The company will re-invest the proceeds from the transaction to strengthen its portfolio in advanced surgery, wound care, orthopaedics, and post-surgical care through organic and inorganic routes.

Based in Watford, UK, Clinisupplies was acquired by Healthium in 2016. The company has a strong portfolio of products in continence care and partners with the NHS to supply quality and cost-effective continence care products.

The move marks Healthium’s strategic decision to focus on innovation and expansion in the organisation's core growth areas. The company will continue to remain in the UK through its surgical consumables portfolio.

Speaking on the strategic move, Anish Bafna, CEO and MD, Healthium Medtech, said, "The divestment of Clinisupplies is a strategic decision in line with our business priorities and gives a solid impetus to our vision of facilitating precision MedTech for every patient globally.”

Paul Cook, CEO, Clinisupplies, further commented, “We are delighted that KKR have invested in Clinisupplies, we share the same ambitious growth plans for the organisation and the whole team looks forward to partnering on the next stage of our growth.